• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China.

作者信息

Wei Yuan-Yuan, Wang Rui-Rui, Zhang Da-Wei, Tu You-Hui, Chen Chang-Shan, Ji Shuang, Li Chun-Xi, Li Xiu-Yong, Zhou Meng-Xi, Cao Wen-Sheng, Han Ming-Feng, Fei Guang-He

机构信息

Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.

Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China; Department of Respiratory and Critical Care Medicine, the Second People's Hospital of Fuyang City, Yingzhou west Road 1088, Fuyang, Anhui 236015, People's Republic of China.

出版信息

J Infect. 2020 Jul;81(1):e89-e92. doi: 10.1016/j.jinf.2020.04.010. Epub 2020 Apr 17.

DOI:10.1016/j.jinf.2020.04.010
PMID:32305487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7162743/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f0/7162743/259857d590c3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f0/7162743/259857d590c3/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/78f0/7162743/259857d590c3/gr1_lrg.jpg

相似文献

1
Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China.重症新型冠状病毒肺炎的危险因素：来自中国安徽167例住院患者的证据。
J Infect. 2020 Jul;81(1):e89-e92. doi: 10.1016/j.jinf.2020.04.010. Epub 2020 Apr 17.
2
Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.中国湖北省襄阳市119例新型冠状病毒肺炎住院患者的临床及实验室指标
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.038. Epub 2020 Apr 10.
3
Children hospitalized for coronavirus disease 2019 (COVID-19): A multicenter retrospective descriptive study.因2019冠状病毒病（COVID-19）住院的儿童：一项多中心回顾性描述性研究。
J Infect. 2020 Aug;81(2):e74-e75. doi: 10.1016/j.jinf.2020.04.045. Epub 2020 May 7.
4
Identification and management of asymptomatic carriers of coronavirus disease 2019 (COVID-19) in China.中国2019冠状病毒病（COVID-19）无症状感染者的发现与管理
Influenza Other Respir Viruses. 2020 Sep;14(5):599-600. doi: 10.1111/irv.12768. Epub 2020 Jun 8.
5
Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis.2019年冠状病毒病（COVID-19）住院患者的急性肾损伤：一项荟萃分析。
J Infect. 2020 Oct;81(4):647-679. doi: 10.1016/j.jinf.2020.05.009. Epub 2020 May 8.
6
[Neurological manifestations of SARS-CoV-2 infection].[新型冠状病毒2型感染的神经学表现]
Semergen. 2020 Aug;46 Suppl 1:106-108. doi: 10.1016/j.semerg.2020.05.004. Epub 2020 May 11.
7
Characteristics of a family cluster of Severe Acute Respiratory Syndrome Coronavirus 2 in Henan, China.中国河南严重急性呼吸综合征冠状病毒2型家庭聚集性病例的特征
J Infect. 2020 Aug;81(2):e46-e48. doi: 10.1016/j.jinf.2020.04.028. Epub 2020 Apr 23.
8
The clinical characteristics of myocardial injury in severe and very severe patients with 2019 novel coronavirus disease.2019新型冠状病毒病重症和危重症患者心肌损伤的临床特征
J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.021. Epub 2020 Mar 21.
9
Importing coronavirus disease 2019 (COVID-19) into China after international air travel.国际航空旅行后将2019冠状病毒病（COVID-19）输入中国。
Travel Med Infect Dis. 2020 May-Jun;35:101620. doi: 10.1016/j.tmaid.2020.101620. Epub 2020 Mar 25.
10
COVID-19: Knowns, Unknowns, and Questions.COVID-19：已知、未知和问题。
mSphere. 2020 Mar 18;5(2):e00203-20. doi: 10.1128/mSphere.00203-20.

引用本文的文献

1
Development and validation of a novel CD4 T cell-related gene signature to detect severe COVID-19.用于检测重症 COVID-19 的新型 CD4 T 细胞相关基因特征的开发与验证
Clin Transl Med. 2023 Jun;13(6):e1294. doi: 10.1002/ctm2.1294.
2
Learning from real world data about combinatorial treatment selection for COVID-19.从关于新冠病毒组合治疗选择的真实世界数据中学习。
Front Artif Intell. 2023 Apr 3;6:1123285. doi: 10.3389/frai.2023.1123285. eCollection 2023.
3
Clinical manifestations of COVID-19 in patients with asthma, hypertension, and diabetes mellitus.

本文引用的文献

1
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
2
Coronavirus 2019-nCoV: A brief perspective from the front line.新型冠状病毒 2019-nCoV：来自前线的简要观察。
J Infect. 2020 Apr;80(4):373-377. doi: 10.1016/j.jinf.2020.02.010. Epub 2020 Feb 25.
3
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
COVID-19 患者的哮喘、高血压和糖尿病的临床表现。
J Med Life. 2022 Dec;15(12):1502-1506. doi: 10.25122/jml-2021-0364.
4
Influence of the Cumulative Incidence of COVID-19 Cases on the Mental Health of the Spanish Out-of-Hospital Professionals.新冠肺炎病例累积发病率对西班牙非医院专业人员心理健康的影响。
J Clin Med. 2022 Apr 15;11(8):2227. doi: 10.3390/jcm11082227.
5
An Updated Review on Complicated Mechanisms of COVID-19 Pathogenesis and Therapy: Direct Viral Damage, Renin-angiotensin System Dysregulation, Immune System Derangements, and Endothelial Dysfunction.关于新冠病毒发病机制与治疗复杂机制的最新综述：病毒直接损伤、肾素-血管紧张素系统失调、免疫系统紊乱及内皮功能障碍
Infect Disord Drug Targets. 2022;22(7):81-91. doi: 10.2174/1871526522666220321153712.
6
The Association between TNF-α, IL-6, and Vitamin D Levels and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis.肿瘤坏死因子-α、白细胞介素-6与维生素D水平与新型冠状病毒肺炎严重程度及死亡率之间的关联：一项系统评价与Meta分析
Pathogens. 2022 Feb 1;11(2):195. doi: 10.3390/pathogens11020195.
7
A new screening tool for SARS-CoV-2 infection based on self-reported patient clinical characteristics: the COV-ID score.基于患者自我报告临床特征的 SARS-CoV-2 感染新型筛查工具：COV-ID 评分。
BMC Infect Dis. 2022 Feb 24;22(1):187. doi: 10.1186/s12879-022-07164-1.
8
Epidemiological and clinical risk factors related to severe COVID-19 in Iran: a multi-center study.伊朗与严重 COVID-19 相关的流行病学和临床危险因素：一项多中心研究。
BMC Infect Dis. 2022 Feb 23;22(1):184. doi: 10.1186/s12879-022-07165-0.
9
Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review.当前干扰素 α 在治疗 2019 冠状病毒病中的应用：全面综述。
Cytokine Growth Factor Rev. 2022 Feb;63:34-43. doi: 10.1016/j.cytogfr.2022.01.001. Epub 2022 Jan 13.
10
SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD - Possible Implications for Interstitial Fibrosis.SARS-CoV-2（COVID-19）在吸烟者和 COPD 小气道、2 型肺泡细胞和肺泡巨噬细胞中的粘附位点蛋白上调——可能对间质纤维化的影响。
Int J Chron Obstruct Pulmon Dis. 2022 Jan 11;17:101-115. doi: 10.2147/COPD.S329783. eCollection 2022.
新冠病毒的基因组特征和流行病学：对病毒起源和受体结合的影响。
Lancet. 2020 Feb 22;395(10224):565-574. doi: 10.1016/S0140-6736(20)30251-8. Epub 2020 Jan 30.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
Potential for global spread of a novel coronavirus from China.新型冠状病毒可能会从中国向全球传播。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa011.